Kestra Medical Valuation
| KMTS Stock | 27.30 0.50 1.87% |
At this time, the firm appears to be overvalued. Kestra Medical Techn secures a last-minute Real Value of USD25.49 per share. The latest price of the firm is USD27.3. Our model forecasts the value of Kestra Medical Techn from analyzing the firm fundamentals such as Profit Margin of (1.78) %, current valuation of 1.43 B, and Return On Equity of -1.26 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kestra Medical's valuation include:
Overvalued
Today
Please note that Kestra Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Kestra Medical Techn is based on 3 months time horizon. Increasing Kestra Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kestra stock is determined by what a typical buyer is willing to pay for full or partial control of Kestra Medical Technologies. Since Kestra Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kestra Stock. However, Kestra Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 27.3 | Real 25.49 | Target 29.0 | Hype 27.32 |
The intrinsic value of Kestra Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kestra Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kestra Medical Technologies helps investors to forecast how Kestra stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kestra Medical more accurately as focusing exclusively on Kestra Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kestra Medical's intrinsic value based on its ongoing forecasts of Kestra Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kestra Medical's closest peers.
Kestra Medical Cash |
|
Kestra Medical Total Value Analysis
Kestra Medical Technologies is now anticipated to have valuation of 1.43 B with market capitalization of 1.56 B, debt of 44.31 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Kestra Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.43 B | 1.56 B | 44.31 M |
Kestra Medical Investor Information
About 86.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 3.96. Kestra Medical Techn had not issued any dividends in recent years. Kestra Medical Technologies may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Kestra Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kestra Medical has an asset utilization ratio of 20.23 percent. This implies that the Company is making USD0.2 for each dollar of assets. An increasing asset utilization means that Kestra Medical Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Kestra Medical Profitability Analysis
Taking into consideration Kestra Medical's profitability measurements, Kestra Medical Technologies may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Kestra Medical's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -102.4 M | Current Value -107.6 M | Quarterly Volatility 34.1 M |
For Kestra Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kestra Medical Techn to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kestra Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kestra Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kestra Medical over time as well as its relative position and ranking within its peers.
Kestra Medical Earnings per Share Projection vs Actual
By analyzing Kestra Medical's earnings estimates, investors can diagnose different trends across Kestra Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Kestra Medical Technologies is based on EPS before non-recurring items and includes expenses related to employee stock options.Kestra Medical Ownership Allocation
Kestra Medical Techn maintains a total of 58.35 Million outstanding shares. The majority of Kestra Medical outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kestra Medical Technologies to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kestra Medical Techn. Please pay attention to any change in the institutional holdings of Kestra Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Kestra Medical Profitability Analysis
The company reported the previous year's revenue of 59.81 M. Net Loss for the year was (113.81 M) with profit before overhead, payroll, taxes, and interest of 34.46 M.About Kestra Medical Valuation
The stock valuation mechanism determines Kestra Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Kestra Medical Techn based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kestra Medical. We calculate exposure to Kestra Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kestra Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 27.8 M | 29.2 M | |
| Pretax Profit Margin | (1.71) | (1.80) | |
| Operating Profit Margin | (1.60) | (1.68) | |
| Net Loss | (1.71) | (1.80) | |
| Gross Profit Margin | 0.36 | 0.38 |
Kestra Medical Current Valuation Indicators
Kestra Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kestra Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kestra Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kestra Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kestra Medical's worth.Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.